Seres Therapeutics (MCRB) Current Leases (2019 - 2025)
Historic Current Leases for Seres Therapeutics (MCRB) over the last 7 years, with Q3 2025 value amounting to $9.9 million.
- Seres Therapeutics' Current Leases rose 1885.93% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 million, marking a year-over-year increase of 1885.93%. This contributed to the annual value of $8.7 million for FY2024, which is 5525.33% up from last year.
- Latest data reveals that Seres Therapeutics reported Current Leases of $9.9 million as of Q3 2025, which was up 1885.93% from $9.5 million recorded in Q2 2025.
- Seres Therapeutics' 5-year Current Leases high stood at $9.9 million for Q3 2025, and its period low was $3.6 million during Q4 2022.
- In the last 5 years, Seres Therapeutics' Current Leases had a median value of $6.8 million in 2022 and averaged $7.1 million.
- In the last 5 years, Seres Therapeutics' Current Leases plummeted by 4552.19% in 2022 and then skyrocketed by 8463.63% in 2024.
- Seres Therapeutics' Current Leases (Quarter) stood at $6.6 million in 2021, then plummeted by 45.52% to $3.6 million in 2022, then soared by 55.15% to $5.6 million in 2023, then soared by 55.25% to $8.7 million in 2024, then rose by 14.36% to $9.9 million in 2025.
- Its last three reported values are $9.9 million in Q3 2025, $9.5 million for Q2 2025, and $9.0 million during Q1 2025.